Therapy of autoimmune diseases with antibody to immune response gene products or to T-cell surface markers.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface / Q000276:immunology*; D001327:Autoimmune Diseases / Q000628:therapy*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000628:therapy*; D006649:Histocompatibility Antigens / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D007518:Isoantibodies / Q000627:therapeutic use*; D051379:Mice; D008815:Mice, Inbred Strains / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D006649:Histocompatibility Antigens; D000949:Histocompatibility Antigens Class II; C024138:I-E-antigen; D007518:Isoantibodies; C035678:anti-Thy antibody